Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 4, 2006 - Issue 6
Submit an article Journal homepage
38
Views
6
CrossRef citations to date
0
Altmetric
Review

Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients

Rosario Palacios Unidad de Enfermedades Infecciosas, Hospital Virgen de la Victoria, Málaga, 29010, Spain. [email protected]
,
Isabel Aguilar Unidad de Enfermedades Infecciosas, Hospital Virgen de la Victoria, Málaga, 29010, Spain. [email protected]
,
Ana Hidalgo Unidad de Enfermedades Infecciosas, Hospital Virgen de la Victoria, Málaga, 29010, Spain. [email protected]
&
Jesús Santos Unidad de Enfermedades Infecciosas, Hospital Virgen de la Victoria, Málaga, 29010, Spain. [email protected]
Pages 965-971 | Published online: 10 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jose V Fernandez-Montero, Eugenia Eugenia, Pablo Barreiro, Pablo Labarga & Vicente Soriano. (2013) Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management. Expert Opinion on Drug Safety 12:5, pages 697-707.
Read now
R. Palacios, A. Rivero, I. Santos, M. J. Ríos, M. Castaño, A. del Arco & J. Santos. (2010) Rapid Improvement in Fasting Lipids and Hepatic Toxicity After Switching From Didanosine/Lamivudine to Tenofovir/Emtricitabine in Patients With Toxicity Attributable to Didanosine. HIV Clinical Trials 11:2, pages 118-120.
Read now

Articles from other publishers (4)

Franck Amblard, Dharmeshkumar Patel, Eleftherios Michailidis, Steven J. Coats, Mahesh Kasthuri, Nicolas Biteau, Zahira Tber, Maryam Ehteshami & Raymond F. Schinazi. (2022) HIV nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry 240, pages 114554.
Crossref
Nathan Ford, Marco Vitoria, Meg Doherty & Andy Gray. (2017) Candidates for inclusion in a universal antiretroviral regimen. Current Opinion in HIV and AIDS 12:4, pages 334-338.
Crossref
Juan Berenguer, Juan González, Esteban Ribera, Pere Domingo, Jesús Santos, Pilar Miralles, Mª Angels Ribas, Víctor Asensi, Juan Luis Gimeno, José Antonio Pérez‐Molina, José Alberto Terrón, Juan Miguel Santamaría & Enric Pedrol. (2008) Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903. Clinical Infectious Diseases 47:8, pages 1083-1092.
Crossref
Jesús SantosRosario PalaciosFernando LozanoManuel LópezMaría Carmen GálvezJavier de la TorresLuis Fernando López-CortésMaría José RíosAntonio Rivero. (2008) Long-Term Assessment of Didanosine, Lamivudine, and Efavirenz in Antiretroviral-Naive Patients: 3-Year Follow-Up. AIDS Research and Human Retroviruses 24:1, pages 24-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.